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A method has been developed for rapidly identifying putative G protein-coupled receptors i olated initially as small cDNA fragments, following 
reverse transcription a d polymerase chain reaction (PCR) amplification of mRNA. The method is based upon the use of synthetic oligonucleotides 
deduced from the sequence of the amplified receptor fragments, to direct a RNase H-mediated specific degradation of hybrids formed between 
the oligonucleotides and the corresponding receptor-encoding mRNA. Loss of an agonist-dependent r ceptor response in the Xenopus laevis oocyte 
expression system identifies the amplified receptor f agment. Taking in vitro synthesised serotonin HT2-receptor (SR)-encoding mRNA as a model, 
it was shown that following incubation with RNase H and SR antisense oligonucleotides, injection of this message no longer caused the acquisition 
of agonist-dependent membrane currents in voltage-clamped oocytes. In contrast, when corresponding sense oligonucleotides were used, the 
serotonin-evoked membrane r sponses in oocytes were acquired as normal. The method should allow the identification of receptors which can 
functionally be expressed and measured inXenopus oocytes. 
RNase H; DNA/mRNA hybrid; G protein-coupled receptor; Voltage-clamp; Xenopus laevis oocytes 
1. INTRODUCTION 
The molecular cloning of various G protein-coupled 
receptors has revealed that they all contain 7 segments 
of hydrophobic amino acids which are generally believ- 
ed to constitute transmembrane domains (reviewed in 
[1,2]). In addition to their structural similarity, there is 
a notable degree of amino acid sequence conservation, 
especially within the putative transmembrane domains. 
Based upon this observation, degenerate oligonucleo- 
tide pools deduced from the third and sixth transmem- 
brane domains have been used as primers in the 
polymerase chain reaction [3]. Using this approach, 
several putative members of this receptor superfamily 
have been successfully amplified from either genomic 
DNA or cDNA [3] (and unpublished data). 
Having identified new receptor candidates by se- 
quence and structural homology to known members of 
the G protein-coupled receptor family, one is faced with 
the problem of identifying their ligands. To date, this 
has usually entailed the isolation of a full-size clone 
from an appropriate cDNA library, recloning of the 
cDNA in an expression vector, its expression in 
Xenopus oocytes or a suitable host cell line and the 
subsequent analysis of ligand binding profiles or the 
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measurement of agonist-induced second messenger syn- 
thesis. As an alternative to this approach, a method is 
presented which allows the rapid identification of PCR 
amplified fragments of receptors that can be func- 
tionally expressed in mRNA-injected oocytes. It bears 
the advantage that large numbers of putative receptors 
can be rapidly screened and that a cDNA fragment is 
sufficient for receptor identification. The method is 
based on the RNAse H-mediated selective depletion of 
hybrids formed between antisense oligonucleotides 
deduced from PCR amplified receptor cDNA frag- 
ments and the corresponding receptor-encoding 
mRNA, leading to an absence of acquired ligand- 
dependent membrane responses in voltage-clamped 
oocytes. 
2. MATERIALS AND METHODS 
Isolation of poly(A) ÷ RNA from GH3 cells and rat brains, injection 
of frog oocytes and their electrophysiological recording were carried 
out as previously described [4]. In vitro synthesized RNA encoding 
functional SR was transcribed from a HT2 cDNA clone in a bluescript 
vector (provided by P.H. Seeburg, Heidelberg [5]), using T3 RNA 
polymerase and standard protocols. 
18mer oligonucleotides synthesized by the phosphoamidite 
method, purified by reversed-phase HPLC (C18 column), and 
desalted on NAP 5 columns, were used in sense (ATGGTGATCACC- 
TACTTC; positions 1350-1367) and antisense (GAAGTAGGTGAT- 
CACCAT) orientation derived from the SR cDNA sequence [5]. This 
nucleotide sequence is also conserved in the serotonin HT~c receptor 
in a homologous position [6]. 
2/zg of poly(A) ÷ RNA or 3 ng of in vitro transcribed RNA were an- 
nealed to 120 ng of SR-derived 18mer oligonucleotide (sense or an- 
tisense orientation) in 100 mM KC1 in a vol. of 5/zl at 65°C for 20 min. 
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The annealing mixture was allowed to cool to room temperature over 
a period of 5 rain, placed on ice and diluted with 15/zl of a solution 
containing : 72 U RNase inhibitor (Pharmacia, Freiburg), I U RNase 
H (Gibco/BRL, Eggenstein), 5/zg tRNA, 15 mM MgCl2, 150 mM 
KCI, 30 mM Tris-HCl (pH 7.5), 1.5 mM DTT, and 7.5O7o (w/v) 
sucrose. The mixture was incubated for 1 or 5 rain at 37°C, quenched 
on ice and extracted once with phenol and once with chloroform. 
Nucleic acids were precipitated with ethanol and the precipitates 
washed twice with 70°70 ethanol. The pellets were dissolved in 2/~1 H20 
and 50 nl were injected into oocytes. 
3. RESULTS AND DISCUSSION 
Injection of either at brain poly(A) ÷ RNA or in vitro 
synthesized RNA encoding the SR results in the acquisi- 
tion of serotonin-dependent membrane currents in 
voltage-clamped oocytes [5] (Fig. 1, left). However, 
when the RNA preparations are first annealed to an- 
tisense oligonucleotides deduced from the fifth 
membrane-spanning domain of the SR (for sequence in- 
formation see section 2) and treated with RNAse H 
prior to injection, oocytes do not demonstrate mem- 
brane currents after application of serotonin (Fig. 1, 
middle). In contrast, oocytes injected with RNA 
preparations which were previously annealed to the cor- 
responding sense oligonucleotide and treated with 
RNAse H, still acquire the ability to respond to 
serotonin (Fig. 1, right). This indicates that RNase H in 
combination with short specific antisense oligonucleo- 
tides can be used to deplete atarget mRNA and that this 
can be electrophysiogicaUy assayed in oocytes. 
To demonstrate he specificity of the method, the 
receptor for the tripeptide thyrotropin releasing hor- 
mone (TRH) was assayed in a control experiment. Po- 
ly(A) ÷ RNA from GH3 cells used as source for the TRH 
receptor-encoding mRNA [4] was incubated with either 
the SR sense or antisense oligonucleotides and digested 
with RNase H. Fig. 2 shows that acquired TRH- 
mediated membrane current responses are essentially 
unaffected in oocytes injected with this RNA prepara- 
tion. In addition, similar analysis of a mixture of in 
vitro synthesized SR-encoding RNA and poly(A) + RNA 
from GH3 cells shows that oocytes injected with such a 
mixture previously incubated either with the SR sense 
or antisense oligonucleotides but not treated with 
RNase H, respond with almost equal intensity to TRH 
and serotonin challenges (Fig. 3). However, serotonin 
but not TRH-induced responses, are almost completely 
abolished when the incubation mixtures additionally 
contained RNase H. 
A variety of molecular approaches have been 
adopted to address the cloning of members of the G 
protein-coupled receptor family. These include func- 
tional expression of cloned receptor cDNA in frog 
oocytes, hybrid selection of receptor-encoding mRNAs 
with cloned cDNA and expression of transfected recep- 
tor genes in cell culture followed by identification using 
a cell sorter (reviewed in [2]). Especially powerful has 
been the exploitation of known similarities between the 
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Fig. l RNase H/antisense oligonucleotide-mediated d gradation of 
serotonin HT2 receptor-encoding mRNA. Membrane current profiles 
of oocytes injected with 100 ng of rat brain mRNA (left), with 100 ng 
rat brain mRNA previously annealed to antisense oligonucleotide and 
treated with RNase H (middle) or with 100 ng of rat brain mRNA 
previously annealed to sense oligonucleotide and treated with RNase 
H (right) are shown. The bars indicate the duration of serotonin (10 
/~M) application. 
family of G protein-coupled-receptors  construct 
degenerate oligonucleotide primers for the PCR- 
mediated amplification of putative new family 
members [3]. A problem of this approach is that the 
amplified receptor fragments do not possess all the in- 
formation required to encode a functional receptor and 
must thus be used to isolate a full-size clone from a 
suitable cDNA library. This procedure becomes very 
time-consuming if many clones are to be analysed. 
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Fig. 2. RNase H/serotonin HT2 receptor oligonucleotide treatment 
does not affect TRH-receptor mRNA. Membrane current responses 
of oocytes injected with 100 ng GH3 cell poly(A) ÷ RNA annealed to 
SR sense oligonucleotide (left) or antisense oligonucleotide (right) and 
digested with RNase H. The bars indicate TRH application. 
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Fig. 3. Specific degradation of serotonin HT2 receptor mRNA. A 
mixture of GH3 cell poly(A) + RNA (50 ng) and in vitro SR-encoding 
RNA 075 pg) was injected into oocytes after annealing to SR sense 
or antisense oligonucleotide and after additional digestion with 
RNase H. Groups of injected oocytes were consecutively xposed to 
TRH (open bars) and serotonin (closed bars). Oocytes were alter- 
natively treated first with serotonin or first with TRH. The histogram 
shows the mean values of peak currents obtained after ligand applica- 
tion. 
Some way of utilising the sequence information in- 
herent in such PCR amplified fragments for direct 
receptor identification would greatly expedite these pro- 
cedures. 
It has several times been reported that oligonucleo- 
tide-mediated translation arrest occurs almost quanti- 
tatively in Xenopus oocytes [10-12]. However, initial 
attempts to inject hybrids preformed between rat brain 
poly(A) + RNA and the SR antisense oligonucleotide 
failed to prevent he acquisition of membrane responses 
induced by serotonin (not shown). This was apparently 
not due to the relatively downstream location of the 
oligonucleotide in relation to the initiation codon 
(oligonucleotides correspond to a conserved region of 
the 5th membrane-spanning domain of the serotonin 
receptor family), since formation of hybrids with an 
oligonucleotide spanning the initiator ATG codon of 
the serotonin receptor still failed to prevent he acquisi- 
tion of serotonin responsiveness in hybrid injected 
oocytes (unpublished ata). Such a result might, of 
course, be explained by the presence in rat brain 
poly(A) + RNA of mRNAs encoding other serotonin 
receptor subtypes with poor homology to the 
oligonucleotides used. 
It has recently been demonstrated that RNase 
mediated predigestion of hybrids formed between 
mRNA and antisense oligonucleotides deduced from a 
particular mRNA sequence can be used to specifically 
prevent ranslation of the corresponding protein in the 
rabbit reticulocyte lysate system [9], It thus seemed 
reasonable to suppose that a similar approach utilising 
antisense oligonucleotides deduced from putative PCR 
amplified receptor fragments and predigestion with 
RNase H could be used to deplete specific receptor 
mRNAs prior to expression in Xenopus oocytes. The 
present report shows that RNase H in combination with 
SR antisense oligonucleotides, can specifically and 
selectively degrade the corresponding message, the con- 
sequence being an absence of normally acquired 
agonist-dependent membrane currents in voltage- 
clamped Xenopus oocytes. Sense oligonucleotides 
deduced from the same sequence fail to affect the in- 
tegrity of the SR message. The specificity of the method 
is further illustrated by the fact that functional mRNA 
for the TRH receptor, another G protein-coupled 
receptor family member, is left intact during the diges- 
tion of hybrids with RNase H presumably because of its 
inability to form stable RNA/DNA hybrids with the SR 
antisense oligonucleotide. 
In summary, the method described here should be ap- 
plicable to identifying PCR-amplified clones for recep- 
tors which have been functionally detected in poly(A) + 
RNA-injected oocytes [7,8]. Additionally, it seems 
probable that new subtypes of already known receptors 
might be identified by this approach. 
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